114 related articles for article (PubMed ID: 26861460)
1. Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer.
Yan P; Klingbiel D; Saridaki Z; Ceppa P; Curto M; McKee TA; Roth A; Tejpar S; Delorenzi M; Bosman FT; Fiocca R
Clin Cancer Res; 2016 Jun; 22(12):3037-47. PubMed ID: 26861460
[TBL] [Abstract][Full Text] [Related]
2. High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis.
Isaksson-Mettävainio M; Palmqvist R; Dahlin AM; Van Guelpen B; Rutegård J; Oberg A; Henriksson ML
Int J Cancer; 2012 Aug; 131(4):779-88. PubMed ID: 21964812
[TBL] [Abstract][Full Text] [Related]
3. Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.
Davison JM; Hartman DA; Singhi AD; Choudry HA; Ahrendt SA; Zureikat AH; Ramalingam L; Nikiforova M; Pai RK
Am J Surg Pathol; 2014 May; 38(5):583-92. PubMed ID: 24618609
[TBL] [Abstract][Full Text] [Related]
4. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
5. Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial.
Bosman FT; Yan P; Tejpar S; Fiocca R; Van Cutsem E; Kennedy RD; Dietrich D; Roth A
Clin Cancer Res; 2009 Sep; 15(17):5528-33. PubMed ID: 19690194
[TBL] [Abstract][Full Text] [Related]
6. Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients.
Mesker WE; Liefers GJ; Junggeburt JM; van Pelt GW; Alberici P; Kuppen PJ; Miranda NF; van Leeuwen KA; Morreau H; Szuhai K; Tollenaar RA; Tanke HJ
Cell Oncol; 2009; 31(3):169-78. PubMed ID: 19478385
[TBL] [Abstract][Full Text] [Related]
7. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
8. Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival.
Kloth JN; Kenter GG; Spijker HS; Uljee S; Corver WE; Jordanova ES; Fleuren GJ; Gorter A
Mod Pathol; 2008 Jul; 21(7):866-75. PubMed ID: 18425078
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.
Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK
Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344
[TBL] [Abstract][Full Text] [Related]
10. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.
Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901
[TBL] [Abstract][Full Text] [Related]
12. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
13. Loss of Smad4 expression predicts liver metastasis in human colorectal cancer.
Losi L; Bouzourene H; Benhattar J
Oncol Rep; 2007 May; 17(5):1095-9. PubMed ID: 17390050
[TBL] [Abstract][Full Text] [Related]
14. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
[TBL] [Abstract][Full Text] [Related]
15. Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.
den Uil SH; Coupé VM; Linnekamp JF; van den Broek E; Goos JA; Delis-van Diemen PM; Belt EJ; van Grieken NC; Scott PM; Vermeulen L; Medema JP; Bril H; Stockmann HB; Cormier RT; Meijer GA; Fijneman RJ
Br J Cancer; 2016 Dec; 115(12):1565-1574. PubMed ID: 27855440
[TBL] [Abstract][Full Text] [Related]
16. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
[TBL] [Abstract][Full Text] [Related]
17. Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.
Koretz K; Schlag P; Boumsell L; Möller P
Am J Pathol; 1991 Mar; 138(3):741-50. PubMed ID: 2000944
[TBL] [Abstract][Full Text] [Related]
18. A study of Smad4 and Smad7 expression in surgically resected samples of gastric adenocarcinoma and their correlation with clinicopathological parameters and patient survival.
Zizi-Sermpetzoglou A; Myoteri D; Arkoumani E; Voultsos M; Marinis A
J BUON; 2014; 19(1):221-7. PubMed ID: 24659668
[TBL] [Abstract][Full Text] [Related]
19. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
